VISTAKONŽ Pharmaceuticals, LLC    SantenŽ Pharmaceutical, Co., LTD. T.R.U.S.T. QUIXIN® to keep you covered.

PEDIATRICIANS

Comfortable Administration with Little or No Stinging

  • 97%-99% of patients did not report discomfort
  • Near-neutral pH (6.5)
  • No corneal precipitates
  • 1%-3% of patients experienced any of the most frequent adverse events: transient decreased vision, fever, foreign body sensation, headache, transient ocular burning, ocular pain or discomfort, pharyngitis, and photophobia

Events reported in less than 1% of patients include allergic reactions, lid edema, ocular dryness, and ocular itching. QUIXINŽ is contraindicated in patients with a history of hypersensitivity to levofloxacin, to other quinolones, or to any of the components of this medication.